Literature DB >> 24129556

Genetic associations in diabetic nephropathy.

Antien L Mooyaart1.   

Abstract

Diabetic nephropathy is a complex disease, caused by both environmental and genetic factors. As in most complex diseases, genetic association studies in diabetic nephropathy showed inconsistent results. In retrospect, studies with small sample sizes, given what are now known to be small odds ratios, were partially responsible for this poor replication record. Furthermore, the low prior probability in complex genetics and multiple testing played a role. Results become more consistent when one only considers those that were replicated. In a large meta-analysis study including only replicated associated genetic variants, 24 genetic variants in 16 genes were found to be associated with diabetic nephropathy. These genetic variants may provide novel biological insight. In particular, rare variants with a large effect found by hypothesis-free approaches (genome-wide association scans, next-generation sequencing) may open new avenues of discovery.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24129556     DOI: 10.1007/s10157-013-0874-9

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  23 in total

1.  Assessing the probability that a positive report is false: an approach for molecular epidemiology studies.

Authors:  Sholom Wacholder; Stephen Chanock; Montserrat Garcia-Closas; Laure El Ghormli; Nathaniel Rothman
Journal:  J Natl Cancer Inst       Date:  2004-03-17       Impact factor: 13.506

Review 2.  Genome-wide association studies for complex traits: consensus, uncertainty and challenges.

Authors:  Mark I McCarthy; Gonçalo R Abecasis; Lon R Cardon; David B Goldstein; Julian Little; John P A Ioannidis; Joel N Hirschhorn
Journal:  Nat Rev Genet       Date:  2008-05       Impact factor: 53.242

3.  Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy.

Authors:  E R Seaquist; F C Goetz; S Rich; J Barbosa
Journal:  N Engl J Med       Date:  1989-05-04       Impact factor: 91.245

Review 4.  Epidemiologic approach to the etiology of type I diabetes mellitus and its complications.

Authors:  A S Krolewski; J H Warram; L I Rand; C R Kahn
Journal:  N Engl J Med       Date:  1987-11-26       Impact factor: 91.245

5.  Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL.

Authors:  Stefano Romeo; Len A Pennacchio; Yunxin Fu; Eric Boerwinkle; Anne Tybjaerg-Hansen; Helen H Hobbs; Jonathan C Cohen
Journal:  Nat Genet       Date:  2007-02-25       Impact factor: 38.330

Review 6.  Rare and common variants: twenty arguments.

Authors:  Greg Gibson
Journal:  Nat Rev Genet       Date:  2012-01-18       Impact factor: 53.242

Review 7.  Genetic mapping in human disease.

Authors:  David Altshuler; Mark J Daly; Eric S Lander
Journal:  Science       Date:  2008-11-07       Impact factor: 47.728

8.  Clinical risk factors, DNA variants, and the development of type 2 diabetes.

Authors:  Valeriya Lyssenko; Anna Jonsson; Peter Almgren; Nicoló Pulizzi; Bo Isomaa; Tiinamaija Tuomi; Göran Berglund; David Altshuler; Peter Nilsson; Leif Groop
Journal:  N Engl J Med       Date:  2008-11-20       Impact factor: 91.245

9.  Genetic associations in diabetic nephropathy: a meta-analysis.

Authors:  A L Mooyaart; E J J Valk; L A van Es; J A Bruijn; E de Heer; B I Freedman; O M Dekkers; H J Baelde
Journal:  Diabetologia       Date:  2010-12-03       Impact factor: 10.122

10.  Why most published research findings are false.

Authors:  John P A Ioannidis
Journal:  PLoS Med       Date:  2005-08-30       Impact factor: 11.613

View more
  12 in total

Review 1.  Association between PAI-1 4G/5G polymorphism and diabetic nephropathy: a meta-analysis in the Chinese population.

Authors:  Wen-Feng Gao; Ying-Bo Guo; Yu Bai; Xin-Yu Ding; Yong-Ji Yan; Zhen-Qi Wu
Journal:  Int Urol Nephrol       Date:  2016-06-06       Impact factor: 2.370

Review 2.  The Prevalence and Management of Diabetic Nephropathy in Asia.

Authors:  Yasuhiko Tomino; Tomohito Gohda
Journal:  Kidney Dis (Basel)       Date:  2015-04-30

Review 3.  Administration of mesenchymal stem cells in diabetic kidney disease: mechanisms, signaling pathways, and preclinical evidence.

Authors:  Yuexin Zhu; Manyu Luo; Xue Bai; Yan Lou; Ping Nie; Shan Jiang; Jicui Li; Bing Li; Ping Luo
Journal:  Mol Cell Biochem       Date:  2022-04-25       Impact factor: 3.396

4.  [Diabetic nephropathy: current diagnostics and treatment].

Authors:  S Werth; H Lehnert; J Steinhoff
Journal:  Internist (Berl)       Date:  2015-05       Impact factor: 0.743

5.  IL10 haplotypes are associated with diabetic nephropathy susceptibility in patients from western Mexico.

Authors:  Luz E Chavarria-Buenrostro; Jorge Hernandez-Bello; Jose F Muñoz-Valle; Jose Macias-Barragan; Liliana B Hernandez-Carrillo; Jorge F Topete-Reyes; Renato Parra-Michel; Maria G Ramirez-Dueñas; Pedro E Sanchez-Hernandez; Ana L Pereira-Suarez; Eden Oceguera-Contreras; Margarita Montoya-Buelna
Journal:  J Clin Lab Anal       Date:  2018-10-21       Impact factor: 2.352

6.  COL4A3 Gene Variants and Diabetic Kidney Disease in MODY.

Authors:  Yiting Wang; Junlin Zhang; Yingwang Zhao; Shanshan Wang; Jie Zhang; Qianqian Han; Rui Zhang; Ruikun Guo; Hanyu Li; Li Li; Tingli Wang; Xi Tang; Changzheng He; Geer Teng; Weiyue Gu; Fang Liu
Journal:  Clin J Am Soc Nephrol       Date:  2018-07-16       Impact factor: 8.237

Review 7.  Diabetic nephropathy - complications and treatment.

Authors:  Andy Kh Lim
Journal:  Int J Nephrol Renovasc Dis       Date:  2014-10-15

8.  The real culprit behind diabetic nephropathy: impaired renal autoregulation?

Authors:  Ruisheng Liu
Journal:  Physiol Rep       Date:  2017-03

9.  The Role of ERRFI1+808T/G Polymorphism in Diabetic Nephropathy.

Authors:  Saeedeh Asgarbeik; Mahsa Mohammad Amoli; Samaneh Enayati; Fatemeh Bandarian; Ensieh Nasli-Esfahani; Katayoon Forouzanfar; Farideh Razi; Seyed Abdolhamid Angaji
Journal:  Int J Mol Cell Med       Date:  2019-06-15

10.  MicroRNA-499a (rs3746444A/G) gene variant and susceptibility to type 2 diabetes-associated end-stage renal disease.

Authors:  Manal S Fawzy; Essam Al Ageeli; Saeed Awad Al-Qahtani; Baraah T Abu Alsel; Shahad W Kattan; Walla Alelwani; Eman A Toraih
Journal:  Exp Ther Med       Date:  2021-11-22       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.